AccuStem Sciences, Inc.
ACUT
$0.55
$0.1330.95%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 330.10K | 296.80K | 236.50K | 503.40K | 156.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 372.10K | 328.20K | 278.20K | 526.60K | 246.00K |
| Operating Income | -372.10K | -328.20K | -278.20K | -526.60K | -246.00K |
| Income Before Tax | -372.10K | -328.20K | -278.20K | -526.60K | -246.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -372.10K | -328.20K | -278.20K | -526.60K | -246.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -372.10K | -328.20K | -278.20K | -526.60K | -246.00K |
| EBIT | -372.10K | -328.20K | -278.20K | -526.60K | -246.00K |
| EBITDA | -371.20K | -327.30K | -277.30K | -525.70K | -245.10K |
| EPS Basic | -0.03 | -0.03 | -0.02 | -0.05 | -0.02 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.01 |
| EPS Diluted | -0.03 | -0.03 | -0.02 | -0.05 | -0.02 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 11.70M | 11.35M | 11.35M | 11.35M | 11.35M |
| Average Diluted Shares Outstanding | 11.70M | 11.35M | 11.35M | 11.35M | 11.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |